Literature DB >> 10388599

Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease.

A M Liu1, M Ghazizadeh, Z Onouchi, G Asano.   

Abstract

Kawasaki disease (KD) is an acute febrile mucocutaneous lymph node syndrome with multisystemic vasculitis affecting mainly infants and children. Although several studies on cardiovascular lesions in KD have been done at the light microscopic level, the ultrastructural characteristics and incidences of these lesions have not been well defined. In order to investigate the myocardial and coronary microvascular sequelae in KD, we performed an ultrastructural study on endomyocardial biopsy specimens obtained during follow-up from 54 patients who had typical clinical manifestations of KD, of whom 47 had associated coronary aneurysms as demonstrated by coronary arteriography (CAG) or two-dimensional echocardiography in the acute or healed stage. The average age of onset was 2.2 years old and the duration of illness was from 2 months to 23 years. Follow-up CAG showed that the coronary aneurysms persisted in 33 of the 47 patients (8 with associated stenosis) and resolved in the remaining 14 patients. Ultrastructurally, the myocardial changes revealed hypertrophy, various degrees of degeneration, proliferation and abnormality of mitochondria, infiltration of a small number of lymphocytes, and fibrosis. The coronary microvascular lesion was characterized by microvascular dilatation, endothelial cell injury, platelet aggregation with thrombosis, and stenotic lumen with thickened walls in the small arterioles. It persisted after convalescent stage even up to 23 years and closely correlated with the myocardial sequelae. Moreover, significantly increased incidences of myocardial and coronary microvascular lesions were found in patients with coronary artery lesion. These findings suggest the coronary microvascular lesion as a possible underlying factor of persistent sequelae in KD. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10388599     DOI: 10.1006/mvre.1999.2155

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  12 in total

1.  Deterioration of cutaneous microcirculatory status of Kawasaki disease.

Authors:  Ming-Yii Huang; Joh-Jong Huang; Teh-Yang Huang; Monesha Gupta-Malhotra; Fei-Kai Syu
Journal:  Clin Rheumatol       Date:  2012-02-04       Impact factor: 2.980

2.  Ventricular repolarisation during exercise challenge occurring late after Kawasaki disease.

Authors:  Hugo Gravel; Nagib Dahdah; Anne Fournier; Marie-Ève Mathieu; Daniel Curnier
Journal:  Pediatr Cardiol       Date:  2012-02-18       Impact factor: 1.655

3.  Myocardial fibrosis after adrenergic stimulation as a long-term sequela in a mouse model of Kawasaki disease vasculitis.

Authors:  Harry H Matundan; Jon Sin; Magali Noval Rivas; Michael C Fishbein; Thomas J Lehman; Shuang Chen; Roberta A Gottlieb; Timothy R Crother; Masanori Abe; Moshe Arditi
Journal:  JCI Insight       Date:  2019-02-07

4.  Global Myocardial Strain in Multisystem Inflammatory Syndrome in Children, Kawasaki Disease, and Healthy Children: A Network Meta-Analysis.

Authors:  Kaiwei Liu; Jiahui Yu; Guang Song
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

5.  High Sensitivity C Reactive Protein (hs-CRP) in Adolescent and Young Adult Patients with History of Kawasaki Disease.

Authors:  Yung-Chuan Chen; Ching-Tsuen Shen; Nan-Koong Wang; Yi-Ling Huang; Hsin-Hui Chiu; Chun-An Chen; Shuenn-Nan Chiu; Ming-Tai Lin; Jou-Kou Wang; Mei-Hwan Wu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

6.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

7.  The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies.

Authors:  E Grunebaum; M Blank; S Cohen; A Afek; J Kopolovic; P L Meroni; P Youinou; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

8.  IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.

Authors:  M Gorelik; Y Lee; M Abe; T Andrews; L Davis; J Patterson; S Chen; T R Crother; G J Aune; M Noval Rivas; M Arditi
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

Review 9.  Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.

Authors:  Nagib Dahdah; Anne Fournier
Journal:  Diagnostics (Basel)       Date:  2013-01-10

Review 10.  Current perspectives on Kawasaki disease.

Authors:  Monesha Gupta-Malhotra; P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.